Risk of bleeding after ground-level falls in elderly patients with atrial fibrillation and warfarin therapy.

OBJECTIVES: The aim of this study was to investigate bleeding risk in patients treated with VKAs after ground-level falls, considering the type and severity of bleeding. METHODS: The study was designed as a retrospective cohort study and included a total of 204 elderly patients aged > 65 years treated for AF continuously with warfarin for more than 3 years. Data were obtained from hospital registries in Bratislava, Slovakia. A 5-year assessment of death/survival was performed to determine mortality. RESULTS: There was no statistically significant difference in severe bleeding (2.13 % with falls vs 2.55 % without, p = 1) and 5-year mortality (45 % and 38 % respectively, p = 0.3987) based on the presence of falls. Multivariate analysis, after adjustment for age, CHA2DS2VASc, HASBLED, stroke history, labile INR and number of falls showed that only HASBLED score was a statistically significant contributor (CI: 1.0245 - 1.0919, p = 0.0007) to severe bleeding. There was statistically significant difference in severe bleeding (18 % vs 0 %, p = 0.0132) between patients suffering from spontaneous and bleeding after falls and also when comparing individual bleeding episodes (12 % vs 1 %, p < 0.0001). There was no statistically significant difference in 5-year mortality between the two groups (43 % vs 42 % respectively, p = 0.3931). CONCLUSIONS: Our results show that occurrence of falls in AF patients treated with VKAs have no significant impact on the incidence of severe bleeding and 5-year mortality and that spontaneous bleeding was associated with a significantly higher risk of severe bleeding compared to bleeding after falling (Tab. 4, Ref. 30).

The role of diabetes mellitus in the effectiveness of intradialytic exercise intervention on patients' muscle function.

INTRODUCTION: The purpose of this study is to identify the role of diabetes mellitus in the effectiveness of intradialytic exercise intervention among haemodialysis patients. METHODS: In this multicentre study 90 dialysed patients were allocated to the experimental (EXG, n=57) or control group (CNG, n=33). In EXG, we included 20 diabetic and 37 non-diabetic patients. In CNG, we enrolled 8 diabetic and 25 non-diabetic patients. EXG underwent a 12-week supervised, progressive, intradialytic resistance training programme, while CNG stayed inactive during dialysis. Baseline, post-interventional and post-follow-up assessments of maximal force during hip extension (HE), hip flexion (HF) and knee extension (KE) contractions were completed in both groups of patients. RESULTS: HE increased in diabetic and non-diabetic EXG patients (diabetic EXG, change: +14.5N; 95% CI=-5.5 to +34.5; non-diabetic EXG, +18.6N; 95% CI=+3.4 to +33.8) and diabetic CNG patients (change: +17.9N; 95% CI=-9.2 to +44.9). Only non-diabetic CNG patients experienced a decrease in HE (change: -22.8N; 95% CI=-36.9 to -8.7, P<.05). CONCLUSIONS: Resistance training improved muscle function among dialysis patients regardless of the presence of diabetes mellitus. We found that non-diabetic patients lose their muscle function extensively during inactivity, while diabetic patients retain their muscle function.

Association Between Apelin and Atrial Fibrillation in Patients With High Risk of Ischemic Stroke.

Background: Atrial fibrillation (AF) is associated with high risk of stroke preventable by timely initiation of anticoagulation. Currently available screening tools based on ECG are not optimal due to inconvenience and high costs. Aim of this study was to study the diagnostic value of apelin for AF in patients with high risk of stroke. Methods: We designed a multicenter, matched-cohort study. The population consisted of three study groups: a healthy control group (34 patients) and two matched groups of 60 patients with high risk of stroke (AF and non-AF group). Apelin levels were examined from peripheral blood. Results: Apelin was significantly lower in AF group compared to non-AF group (0.694 ± 0.148 vs. 0.975 ± 0.458 ng/ml, p = 0.001) and control group (0.982 ± 0.060 ng/ml, p < 0.001), respectively. Receiver operating characteristic (ROC) analysis of apelin as a predictor of AF scored area under the curve (AUC) of 0.658. Apelin's concentration of 0.969 [ng/ml] had sensitivity = 0.966 and specificity = 0.467. Logistic regression based on manual feature selection showed that only apelin and NT-proBNP were independent predictors of AF. Logistic regression based on selection from bivariate analysis showed that only apelin was an independent predictor of AF. A logistic regression model using repeated stratified K-Fold cross-validation strategy scored an AUC of 0.725 ± 0.131. Conclusions: Our results suggest that apelin might be used to rule out AF in patients with high risk of stroke.

The role of diabetes mellitus in the effectiveness of intradialytic exercise intervention on patients' muscle function.

INTRODUCTION: The purpose of this study is to identify the role of diabetes mellitus in the effectiveness of intradialytic exercise intervention among haemodialysis patients. METHODS: In this multicentre study 90 dialysed patients were allocated to the experimental (EXG, n=57) or control group (CNG, n=33). In EXG, we included 20 diabetic and 37 non-diabetic patients. In CNG, we enrolled 8 diabetic and 25 non-diabetic patients. EXG underwent a 12-week supervised, progressive, intradialytic resistance training programme, while CNG stayed inactive during dialysis. Baseline, post-interventional and post-follow-up assessments of maximal force during hip extension (HE), hip flexion (HF) and knee extension (KE) contractions were completed in both groups of patients. RESULTS: HE increased in diabetic and non-diabetic EXG patients (diabetic EXG, change: +14.5N; 95% CI=-5.5 to +34.5; non-diabetic EXG, +18.6N; 95% CI=+3.4 to +33.8) and diabetic CNG patients (change: +17.9N; 95% CI=-9.2 to +44.9). Only non-diabetic CNG patients experienced a decrease in HE (change: -22.8N; 95% CI=-36.9 to -8.7, P<.05). CONCLUSIONS: Resistance training improved muscle function among dialysis patients regardless of the presence of diabetes mellitus. We found that non-diabetic patients lose their muscle function extensively during inactivity, while diabetic patients retain their muscle function.

A 10-yr follow-up study for the detection of peripheral neuropathy in young patients with type 1 diabetes.

OBJECTIVE: The main objective of this work was to follow-up the development of diabetic neuropathy (DN) and its severity in patients with type 1 diabetes over 10 yr. Our intention was also to observe risk factor changes and verify which of them influence the development of neuropathy. The other objective was longitudinal study of electrophysiological parameters, focusing on the early diagnosis of DN. METHODS: The prospective study comprised of 62 young patients with type 1 diabetes mellitus (DM) aged 13.9 ± 5.89 yr, with diabetes duration of 5.56 ± 5.11 yr, treated with an intensified insulin regimen. All patients underwent a detailed clinical neurological examination, nerve conduction study (NCS) and biothesiometry three times (baseline, after 5 yr, after 10 yr). RESULTS: During the follow-up there was an increase in DN prevalence from 24.2% to 62.9% (p < 0.001). The proportion of patients with subclinical neuropathy increased from 17.7% to 46.8% (p < 0.001) and patients with clinical neuropathy from 6.5% to 16.1% (p < 0.001). The main contribution factors for rapid growth of the DN prevalence were poor glycaemic control, diabetes duration and patient's age. Regarding the conduction parameters, the most significant changes were observed in sural nerve SNAP amplitude (-5.2 m/s, p < 0.001) and sural nerve conduction velocity (-8.2 uV, p < 0.001). In contrast, the least significant changes were in peroneal nerve CMAP amplitude (-0.65 mV, p = 0.008). CONCLUSIONS: The results of the study demonstrated a progressive increase in the DN prevalence over time, in particular its subclinical stages. The long-term poor glycaemic control was a determining factor in the rapid DN development. The sensory conduction parameters deteriorated faster than the motor parameters. The present study is one of few of those in type 1 DM, which in relation to risk factors assess not only the presence of neuropathy, but also its severity. The results support the necessity of a regular diagnostic search for DN in diabetic children.

Ten-year all-cause mortality in hospitalized non-surgical patients based on nutritional status screening.

OBJECTIVE: Malnutrition is common in patients admitted to hospital due to acute illness and contributes to negative patient outcomes. In Slovakia there is a lack of relevant data on malnutrition in hospitalized patients, particularly based on chronic co-morbidity and survival. The aim of the present study was to explore the prevalence of malnutrition in hospitalized chronic patients, its relationship to co-morbidity and its impact on 10-year survival. DESIGN: Retrospective cohort study. SETTING: Nutritional status was estimated by Subjective Global Assessment (SGA), BMI and serum albumin level. Survival was assessed from the National Insurance Registry over a 10-year period. The association between nutritional status measured by SGA and 10-year survival controlling for age, gender, BMI and serum albumin was analysed using Cox regression. SUBJECTS: Data were taken from the medical records of 202 consecutively admitted chronic patients. Results Median age was 63·5 years; 55·4 % were males; median BMI was 25·9 kg/m2; median serum albumin level was 39·0 g/l. Based on SGA evaluation, 38·1 % did not have sufficient nutritional status (SGA classification B and C). Malnutrition was more common in patients who were older (P=0·023), with lower BMI (P<0·001), who had gastrointestinal (P=0·049) and oncologic co-morbidity (P=0·021) and lower albumin level (P=0·049). In-hospital mortality was 3 %, but during the following 10 years 52 % died. Cox regression analysis controlling for age, gender, BMI and serum albumin showed that SGA was an independent predictor of death (hazard ratio=1·55; 95 % CI 1·04, 2·32; P=0·031). CONCLUSIONS: SGA is a simple screening tool that can be routinely used in hospitalized Slovak medical patients to predict the risk of death. Improving patient nutrition could thus reduce mortality.

Body composition monitor assessing malnutrition in the hemodialysis population independently predicts mortality.

OBJECTIVE: Malnutrition is a known predictor of mortality in the general and hemodialysis populations. However, diagnosing malnutrition in dialysis patients remains problematic. Body composition monitoring (BCM) is currently used mainly for assessing overhydratation in hemodialysis patients, but it also offers the possibility of evaluating nutrition status. This study explored whether malnutrition diagnosed by BCM predicts mortality at up to 54 months follow-up in prevalent hemodialysis patients. DESIGN: This was a retrospective epidemiology cohort study. Dialysis patients with baseline BCM measurement between 2008 and 2013 were enrolled. The observation period was up to 54 months follow-up. SUBJECTS: A total sample consisted of 960 chronic hemodialysis participants. INTERVENTION: All data were retrieved from medical records. Nutrition status was estimated by BCM; malnutrition was diagnosed as lean tissue index less than 10% of the normal value. MAIN OUTCOME MEASURE: Cox regression was performed to identify whether low LTI predicted mortality in hemodialysis patients. RESULTS: BCM-diagnosed malnutrition (hazard ratio [HR] 1.66; 95% confidence interval [CI] 1.1; 2.44), higher age (HR 1.05; 95% CI 1.03; 1.07), longer dialysis vintage (HR 1.00; 95% CI 1.00; 1.00), central venous catheter use (HR 1.96; 95% CI 1.28; 2.99), and low serum albumin (HR 0.91; 95% CI 0.87; 0.95) contributed significantly to the Cox regression model on mortality. CONCLUSION: BCM-diagnosed malnutrition in chronic hemodialysis patients is an independent predictor of mortality at up to 54 months follow-up and is associated with a 1.66-fold higher risk of dying compared with normal nutrition status. Whether intervention (e.g., nutritional supplementation) might improve nutrition and reduce the higher risk of mortality in malnutrition patients on hemodialysis remains a challenge for future research.